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Agents that Reverse UV-Induced Immune
Suppression and Photocarcinogenesis Affect DNA
Repair
Coimbatore S. Sreevidya1, Atsushi Fukunaga2, Noor M. Khaskhely3, Taro Masaki2, Ryusuke Ono2,
Chikako Nishigori2 and Stephen E. Ullrich1
UV exposure induces skin cancer, in part, by inducing immune suppression. Repairing DNA damage,
neutralizing the activity of cis-urocanic acid, and reversing oxidative stress abrogate UV-induced immune
suppression and skin cancer induction, suggesting that DNA, UCA, and lipid photo-oxidation serve as UV
photoreceptors. What is not clear is whether signaling through each of these different photoreceptors activates
independent pathways to induce biological effects or whether there is a common checkpoint where these
pathways converge. Here, we show that agents known to reverse photocarcinogenesis and photoimmune
suppression, such as platelet-activating factor (PAF) and serotonin (5-HT) receptor antagonists, regulate DNA
repair. Pyrimidine dimer repair was accelerated in UV-irradiated mice injected with PAF and 5-HT receptor
antagonists. Nucleotide excision repair (NER), as measured by unscheduled DNA synthesis, was accelerated by
PAF and 5-HT receptor antagonists. Injecting PAF and 5-HT receptor antagonists into UV-irradiated Xeroderma
pigmentosum complementation group A–deficient mice, which lack the enzymes responsible for NER, did not
accelerate photoproduct repair. Similarly, UV-induced formation of 8-oxo-deoxyguanosine was reduced by PAF
and 5-HT receptor antagonists. We conclude that PAF and 5-HT receptor antagonists accelerate DNA repair
caused by UV radiation, which prevents immune suppression and interferes with photocarcinogenesis.
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INTRODUCTION
The UV radiation found in sunlight is the primary cause of
non-melanoma skin cancer, the most prevalent human
cancer, and UV exposure is implicated in the induction of
melanoma, the most dangerous skin cancer (Boring et al.,
1992). In addition to being a complete carcinogen, UV is
immune suppressive, and the induction of immune suppres-
sion by UV exposure is recognized as a major risk factor for
skin cancer induction (Fisher and Kripke, 1982; Yoshikawa
et al., 1990). UV irradiation induces signature mutations (C to
T and CC to TT transitions) in the p53 tumor suppressor gene,
a critical target for skin cancer formation (reviewed by
Benjamin et al., 2008). Further, UV-induced DNA lesions,
particularly cyclobutane pyrimidine dimer (CPD) formation,
have an essential role in the induction of immune suppression
(Applegate et al., 1989; Vink et al., 1997), identifying DNA as
an important photoreceptor for UV-induced carcinogenesis
and immunosuppression.
DNA is not alone in its ability to act as a photoreceptor for
UV-induced immunosuppression. The isomerization of trans-
UCA to the cis-isomer converts UV radiation into a
biologically recognizable signal that activates immune
suppression (De Fabo and Noonan, 1983). Neutralizing the
activity of cis-urocanic acid (cis-UCA) (Moodycliffe et al.,
1996), or blocking the binding of cis-UCA to its receptor
(5-HT2A) with selective serotonin receptor antagonists, blocks
UV-induced immune suppression (Walterscheid et al., 2006).
Neutralizing the activity of cis-UCA in vivo blocks photo-
carcinogenesis (Beissert et al., 2001).
Evidence from a number of laboratories has also indicated
that membrane phospholipids can absorb UV radiation,
leading to lipid peroxidation and the activation of transcrip-
tion factors, resulting in cytokine release and contributing to
immune suppression (Devary et al., 1993; Simon et al.,
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1994). Moreover, injecting UV-irradiated phospholipids into
mice activates cytokine release and immune suppression,
further supporting a role for lipids as a photoreceptor
(Walterscheid et al., 2006). The lipid mediator of inflamma-
tion, platelet-activating factor (PAF), is secreted by keratino-
cytes almost immediately after UV exposure (Pei et al., 1998),
and activates the transcription of many of the cytokines and
immunomodulatory factors, such as IL-10 and prostaglandin
E2, which drive UV-induced immune suppression. Blocking
the binding of PAF to its receptor blocks UV-induced immune
suppression (Walterscheid et al., 2002). Moreover, UV
exposure promotes oxidative stress, which induces DNA
damage, and the production of oxidized phospholipids, such
as PAF, and treating UV-irradiated mice with antioxidants
blocks UV-induced immune suppression and photocarcino-
genesis (Black et al., 1997).
What is not clear is whether signaling through each of
these different photoreceptors activates independent path-
ways to induce immune suppression and photocarcinogen-
esis or whether there is a common checkpoint where these
pathways converge. Recently, we showed that PAF and 5-HT
receptor antagonists block photocarcinogenesis (Sreevidya
et al., 2008). To determine, in more detail, the mechanisms
involved, we measured the numbers of CPDs in the skin of
antagonist-treated UV-irradiated mice. Initially, we noted that
the numbers of CPDs in the skin of the antagonist-treated,
UV-irradiated mice were similar to those seen in the UV-only
controls. However, as time progressed, UV-induced CPDs
were repaired more rapidly in the receptor antagonist-treated
mice. In view of the importance that CPD formation has in
both carcinogenesis and immune suppression, we asked
whether the mechanism by which diverse agents such as PAF
and 5-HT receptor antagonists reverse immune suppression
and carcinogenesis is by regulating DNA repair. Here, we
present data showing that blocking PAF and cis-UCA from
binding to their receptors modulates DNA repair following
exposure to UV radiation.
RESULTS
Agents that reverse immune suppression accelerate
photoproduct removal
Over the years, a variety of structurally and mechanistically
diverse agents have been used to overcome UV-induced
immune suppression. This is illustrated in Figure 1. Repairing
CPD formation (Figure 1a) by applying T4N5-containing
liposomes (Kripke et al., 1992), neutralizing the activity of
cis-UCA (Figure 1b) (El-Ghorr and Norval, 1995), blocking
PAF receptor binding (Figure 1c) (Walterscheid et al., 2002),
and blocking 5-HT receptor binding (Walterscheid et al.,
2006) (Figure 1d), all interfere with UV-induced immune
suppression. Alternatively, treating mice with PAF, 5-HT, and
cis-UCA all activate immune suppression. We measured the
effect these agents had on the numbers of CPD and
pyrimidine (6–4) pyrimidinone photoproduct (6–4 photopro-
duct) in the skin. Mice were exposed to 2 kJm2 of ultraviolet
B (UVB) radiation and immediately injected with a PAF
receptor antagonist (PCA-4248), or a 5-HT receptor antago-
nist 1-(1-naphthyl)piperazine (1-NPZ), as previously des-
cribed (Walterscheid et al., 2006; Sreevidya et al., 2008). At
various times post irradiation, skin samples were acquired;
DNA was isolated and CPD and 6–4 photoproduct numbers
were determined by immunohistochemistry (Figure 1e and f)
and ELISA (Figure 1g and h). Note that at 1 hour post
irradiation, the numbers of CPDs and 6–4 photoproducts
found in the skin of the mice injected with the receptor
antagonists were similar to the numbers found in mice only
exposed to UV radiation. At 12 and 24 hours post irradiation,
we saw a significant (Po0.05) decrease in the numbers of
CPD and 6–4 photoproducts found in the skin of UV-
irradiated and PAF- and/or 5-HT-antagonist-injected mice,
compared with the UV-irradiated control. By 48 hours, no
significant difference in the numbers of CPD and 6–4
photoproducts found in the skin of the UV-irradiated and
PAF- and/or 5-HT-injected mice, versus the number of CPD
and 6–4 photoproducts found in the skin of the UV-only
controls, was noted. These data indicate that treating
UV-irradiated mice with PAF and 5-HT receptor antagonists
accelerates the repair of UV-induced photoproducts.
Effect of PAF and 5-HT receptor antagonists on unscheduled
DNA repair
UV-induced photoproducts are removed by nucleotide
excision repair (NER), which is routinely detected by
unscheduled DNA synthesis (UDS) (Hanawalt et al., 2003).
Therefore, we asked whether accelerated photoproduct
repair was due to NER. Keratinocytes were pretreated with
a PAF (PCA-4248, 50mM) or a 5-HT (1-NPZ; 25mM) receptor
antagonist, washed, and then UV-irradiated (200 Jm2). The
cells were incubated with BrdU and then stained with anti-
BrdU antibody (Figure 2a). The left panel shows anti-BrdU
staining, the middle panel shows DAPI (40-6-diamidino-2-
phenylindole) staining to illuminate the nuclei, and the right
panel shows a merge of the DAPI and BrdU panels.
Compared with unirradiated control cells, punctate nuclear
staining (arrows), indicative of UDS, was found in cells
exposed to UV radiation (Figure 2a). Treating the cells with
the PAF or the 5-HT receptor antagonist further increased the
number of cells undergoing UDS (35.4% UV only vs 55.4%
UVþPCA 4248, and vs 58.8% UVþ1-NPZ). In addition,
the number of grains per nuclei was counted and we found
that treating the cells with the PAF or 5-HT receptor
antagonists increased the grains per nuclei (Figure 2b). These
data indicate that PAF and 5-HT receptor antagonists
accelerate NER.
Failure of PAF and 5HT receptor antagonists to accelerate DNA
repair in XPA-deficient mice
NER is absent in Xeroderma pigmentosum complementation
group A (XPA/) mice (Hanawalt, 2001). To confirm that
NER is involved in the accelerated DNA repair induced by PAF
and 5-HT receptor antagonists, we measured CPD removal in
XPA/ mice. Wild-type and XPA/ mice were UV-
irradiated and then injected with PAF and 5-HT receptor
antagonists. CPD was observed in wild-type mice 24hours
after UV irradiation. Treating the wild-type mice with a PAF
and/or a 5-HT receptor antagonist accelerated the rate of DNA
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repair (Figure 3a). No removal of CPD was noted when the PAF
and/or the 5-HT receptor antagonists were injected into UV-
irradiated XPA/ mice. In addition, we saw no inhibition of
apoptosis in XPA/ mice injected with PAF or 5-HT receptor
antagonists (Figure 3b). These findings support our hypothesis
that PAF and 5-HT receptor antagonists accelerate the rate of
DNA repair through a mechanism involving NER.
Induction of ROS and DNA damage following treatment with
PAF, 5-HT, and cis-UCA
UV induces oxidative stress, which can lead to free radical
formation and ultimately DNA damage (Bertram and Hass,
2008). Although PAF and 5-HT have been shown to activate
reactive oxygen species (ROS) and apoptosis (Barber et al.,
1998; Breard et al., 2007), it is not clear whether cis-UCA can
DNA damage
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Figure 1. Reversal of immune suppression and acceleration of DNA repair by platelet-activating factor (PAF) and serotonin (5-HT) receptor antagonists. Effect
of agents that repair DNA damage, neutralize cis-urocanic acid (cis-UCA) activity, or block PAF and 5-HT from binding to their receptors on immune
suppression. Mice were exposed to 15 kJm2 of ultraviolet B (UVB) radiation and then treated with (a) T4N5-containing liposomes, (b) monoclonal anti-cis-
UCA, (c) PAF receptor antagonist, and (d) 5-HT receptor antagonist. The effect the various treatments had on UV-induced immune suppression was determined
using a delayed-type hypersensitivity (DTH) assay. The data are expressed as mean footpad swelling±SEM. The asterisk denotes a significant difference
(Po0.05) from the positive control. Effect of PAF and 5-HT receptor antagonists on the numbers of cyclobutane pyrimidine dimmer (CPD) and pyrimidine (6–4)
pyrimidinone photoproducts (6–4 photoproducts). Mice were exposed to 2 kJm2 of UVB radiation and then immediately injected with 1 mM of PCA-4248 or
1mM of 1-(1-naphthyl)piperazine (1-NPZ). At 1 and 24hours post irradiation, skin samples were removed, and (e) CPD or (f) 6–4 photoproducts (PP) were
visualized by immunohistochemistry. Bar¼ 50mm. High-magnification views (400) are shown in the inserts. At various times post irradiation, skin samples
were taken, DNA was isolated, and (g) CDP and (h) 6–4 photoproducts were measured by ELISA. *Indicates a significant difference (Po0.05) from the
UV-only control (Student’s t-test, n¼ 5).
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induce ROS and promote DNA damage. To address this
question, keratinocytes were treated with UV, carbamyl-PAF
(cPAF) (the metabolically stable analog of PAF), 5-HT, and
cis-UCA. The cells were then incubated with 20,70-dichlor-
odihydro-fluorescein diacetate, a dye that is oxidized into the
highly fluorescent product dichlorofluorescein by ROS
(Brubacher and Bols, 2001). Fluorescence was measured by
flow cytometry. The positive controls (UV radiation, cPAF,
and 5-HT) activated ROS production as measured by the
increased numbers of highly fluorescent cells (Figure 4a).
Treatment with cis-UCA also induced ROS formation.
Treating the cells with PCA-4248, or 1-NPZ, reduced the
number of intensely staining fluorescent cells, indicating that
these agents block ROS production. This observation was
confirmed by fluorescent microscopy (Figure 4b). No
fluorescence was found in normal cells, but many fluorescent
cells were found following UV and/or cPAF exposure.
Keratinocytes treated with 5-HT or cis-UCA also emitted a
strong fluorescent signal. Treating the cells with PAF and
5-HT receptor antagonists reduced the fluorescent signal,
supporting the conclusion that PAF, 5-HT, and cis-UCA
activate ROS production.
ROS induces 8-oxo-deoxyguanosine (8-oxo-dG), which is
pre-mutagenic and has been implicated in photocarcinogen-
esis (Le Page et al., 1995). We measured 8-oxo-dG in the skin
of mice injected with PAF and cis-UCA (Figure 5a).
Background levels of 8-oxo-dG were observed in samples
from untreated mice, which is expected because cells express
8-oxo-dG under normal physiological conditions (Wiseman
and Halliwell, 1996). UV irradiation increased 8-oxo-dG
formation. Treating the mice with cPAF and cis-UCA
also increased 8-oxo-dG formation. Treating the mice with
PCA-4248 or 1-NZP reduced UV-induced 8-oxo-dG produc-
tion in the skin. 8-oxo-dG production was measured by ELISA
(Figure 5b). We observed a statistically significant induction
of 8-oxo-dG by cPAF and cis-UCA treatment (Po0.001 vs
normal skin), which was inhibited when the mice were
treated with the respective receptor antagonist. As severe
DNA damage leads to apoptosis, we also asked whether
cPAF and cis-UCA induced apoptosis (Figure 5c). A high
number of TUNEL-positive apoptotic cells were observed in
the skin of the treated mice. As Beneke et al. (2000) showed
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Figure 3. Failure to reverse cyclobutane pyrimidine dimmer (CPD)
formation in PAF and serotonin (5-HT) receptor antagonist-treated
XPA/ mice. Wild-type (WT) or XPA/ mice were exposed to 2 kJm2
of ultraviolet B (UVB) radiation and immediately injected with 1 mM of
PCA-4248 or 1 mM of 1-(1-naphthyl)piperazine (1-NPZ). (a) CPDs were
detected by immunohistochemistry. Bar¼ 50mm. High-magnification views
(400) are shown in the inserts. (b) Apoptosis was detected by TUNEL.
Bar¼200 mm.
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Figure 2. Unscheduled DNA synthesis is accelerated by treating
UV-irradiated mice with PAF and serotonin (5-HT) receptor antagonists.
(a) Pam 212 cells were treated with a PAF (PCA-4248; 50 mM) or a
5-HT (1-(1-naphthyl)piperazine (1-NPZ); 25 mM) receptor antagonist, washed,
and then exposed to 200 Jm2 of ultraviolet B (UVB) radiation. The cells were
incubated with BrdU (3 hours, 371C) and then incubated with anti-BrdU
antibody. The left panels show anti-BrdU staining (red). The center panels
show 40-6-diamidino-2-phenylindole (DAPI) staining of the nuclei. The right
panel shows a merge of the BrdU and DAPI staining. Arrowheads illustrate
nuclei in the S phase; arrows indicate punctate nuclear staining characteristic
of cells undergoing unscheduled DNA synthesis (UDS). The percentage of
cells undergoing UDS in each group is indicated. Bar¼ 50mm.
(b) Quantification of UDS. The number of individual grains per nuclei was
counted. *Indicates a significant difference (Po0.05) from the UV-only
control (Student’s t-test, 50 cells per sample).
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that the cleavage of endogenous Poly (ADP-ribose) polymer-
ase 1 is a marker for apoptotic cell death, we measured the
effect of PAF and 5-HT receptor antagonists on poly(ADP-
ribose) polymerase (PARP) cleavage. Western blotting with
an antibody specific for the cleaved form (89 kDa) of
PARP indicated that UV exposure activated PARP cleavage
(Figure 5d: lanes 2 and 5). Treating the cells with a PAF
(lanes 3 and 6) or a 5-HT (lanes 4 and 7) receptor antagonist
inhibited PARP cleavage. These results confirm that both PAF
and cis-UCA can induce DNA damage, and that blocking the
binding of these inflammatory mediators to their receptors
will block DNA damage.
DISCUSSION
UV-induced DNA mutations are a critical step in the
induction of skin cancer, and compelling evidence from
Kripke and colleagues showed that DNA serves as a photo-
receptor for UV-induced immune suppression (Applegate
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Figure 4. Serotonin (5-HT) and cis-urocanic acid (cis-UCA) induced reactive oxygen species (ROS) formation. Keratinocytes were exposed to ultraviolet B
(UVB) radiation (200 Jm2), or cultured with 10 mM of carbamyl-PAF (cPAF), 50 mM of 5-HT, or 50 mM of cis-UCA. Some of the cells were pretreated with
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et al., 1989; Kripke et al., 1992; Vink et al., 1997).
Compelling data also exist showing that cis-UCA is a UV
photoreceptor (De Fabo and Noonan, 1983) and that
neutralizing its function will also impair photocarcinogenesis
(Beissert et al., 2001) and block the induction of immune
suppression (Moodycliffe et al., 1996; Walterscheid et al.,
2006). Moreover, injecting PAF receptor antagonists into UV-
irradiated mice blocks both immune suppression and
photocarcinogenesis (Walterscheid et al., 2002; Sreevidya
et al., 2008). Conventional wisdom suggests that the reason
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Figure 5. Reduced 8-oxo-deoxyguanosine (8-oxo-dG) lesions following treatment with platelet-activating factor (PAF) and serotonin (5-HT) receptor
antagonists. Mice were exposed to 2 kJm2 of ultraviolet B (UVB) radiation, or injected with 500 nM of carbamyl-PAF (cPAF) or 5mM of cis-urocanic acid (cis-
UCA). Some mice were injected with 1mM of PCA-4248 or 1mM of 1-(1-naphthyl)piperazine (1-NPZ) immediately following irradiation. Skin samples were also
collected after dermal injection of 500 nM of cPAF or 5 mM of cis-UCA. All samples were collected 24 hours post treatment. (a) 8-oxo-dG was detected by
immunohistochemistry. (b) 8-oxo-dG was measured by ELISA. Data are expressed as ng of 8-oxo-dG per 100mg total DNA. P-values were determined by
Student’s t-test (n¼5). (c) Apoptosis (TUNEL) in response to dermal cPAF and cis-UCA injection. Bar¼ 200mm. (d) PARP cleavage is blocked by PAF and 5-HT
receptor antagonists. Keratinocytes were pretreated with PCA 4248 (50 mM) or 1-NPZ (25 mM), washed, and then exposed to 200 Jm2 of UVB radiation. Total
cellular protein was isolated 1 and 24hours post irradiation. Cleaved PARP was measured by western blotting. Equal gel loading was confirmed by staining with
a glyceraldehyde 3-phosphate dehydrogenase (GAPDH)-specific antibody.
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anti-cis-UCA antibody, PAF receptor, and 5-HT receptor
antagonists block photocarcinogenesis is by blocking im-
mune suppression (as illustrated in Figure 1). Undoubtedly,
blocking immune suppression is contributing to some of the
anticancer effects, but our findings illustrate a previously
unreported and as-yet unappreciated mechanism to describe
the anticancer effects previously described. We show that
blocking the binding of cis-UCA to its receptor (5-HT2A), or
blocking the binding of PAF to its receptor, agents that reverse
UV-induced immune suppression and photocarcinogenesis,
also modulate DNA repair. Both UV-induced photoproducts
(CPD and 6–4 photoproducts) were removed following
treatment with PAF and 5-HT receptor antagonists. As this
is an NER-dependent mechanism, we measured UDS.
Treatment with the PAF and 5-HT receptor antagonists
accelerated UDS, indicating that these agents accelerated
NER. Failure of the PAF and 5-HT receptor antagonists to
accelerate DNA repair in XPA/ mice further supports our
hypothesis that these agents affect NER. The implication of
these findings is that UV-induced immunosuppressive agents,
such as PAF and cis-UCA, inhibit DNA repair in vivo. It is
interesting to note that Yarosh et al. (2005) showed that two
classic immunosuppressive drugs, cyclosporine and tacroli-
mus, also inhibit the removal of CPD in UV-irradiated
keratinocytes.
Our findings also indicate that treating mice with cis-UCA,
PAF, and 5-HT induces ROS, leading to oxygen radical
formation and DNA damage, as evidenced by 8-oxo-dG
formation. The induction of ROS by PAF and 5-HT, which
are well-known inflammatory mediators, is documented
(Bussolati et al., 1998; Breard et al., 2007). Although others
have suggested that it is theoretically possible for cis-UCA
to induce ROS (Shen and Ji, 2008), here we provide
direct evidence for cis-UCA-induced ROS and DNA
damage. In addition, we provide data showing that blocking
the binding of cis-UCA and PAF to their receptors blocks
ROS and 8-oxo-dG formation. These findings suggest
that agents used here that reverse UV-induced immune
suppression and photocarcinogenesis may do so by regulat-
ing DNA repair.
Kripke and colleagues clearly showed the role of UV-
induced CPD formation in activating immune suppression.
However, it is equally important to remember that other types
of DNA damage, particularly double-strand breaks, will also
induce immunosuppression and the production of immune
suppressive cytokines in vivo (O’Connor et al., 1996;
Nishigori et al., 1998). We suggest that this is one pathway
by which cis-UCA and PAF are activating immune
suppression, in the absence of the typical UV-induced DNA
damage (Figure 1). 8-oxo-dG formation is indicative of
oxidative DNA damage. Treating keratinocytes, or skin with
PAF, cis-UCA, or 5-HT activates DNA damage, as evidenced
by the upregulation of 8-oxo-dG. Moreover, PAF and 5-HT
receptor antagonists decrease 8-oxo-dG formation in vivo.
Our data indicate that the PAF and 5-HT receptor antagonists
can work at two levels to repair DNA lesions. We see
accelerated repair of both UV-induced photoproducts
(CPD and 6–4 photoproducts) and reduced numbers of
ROS-induced lesions (8-oxo-dG formation) in mice treated
with PAF and 5-HT receptor antagonists. Indeed, these two
observations may be related. Others have shown that ROS
can adversely affect NER. Langie et al. found that NER
capacity as well as the expression of some of the genes
involved in NER is modulated by oxidative stress. Specifi-
cally, they noted an inhibition of NER after exposure to H2O2
(Langie et al., 2007). It may be possible that UV-induced cis-
UCA and PAF are contributing to immune suppression and
photocarcinogenesis not only by inducing DNA damage
through the production of reactive oxygen but also by
inhibiting NER and allowing for the persistence of CPD and
6–4 photoproducts through an ROS-dependent mechanism.
This may help explain why these seemingly disparate agents
block both UV-induced and cis-UCA-induced immune
suppression.
Interleukin-12 is a classic immune modulatory cytokine
that has been shown to reverse UV-induced immune
suppression (Schmitt et al., 1995). Schwarz et al. (2002,
2005) showed that IL-12 treatment reverses UV-induced
apoptosis and immune suppression, in part, by activating
DNA repair. Our findings are reminiscent of the dual
effects of IL-12. For example, blocking PAF from binding to
its receptor restores immune competence, by suppressing
prostaglandin E2 and IL-10 production (Walterscheid et al.,
2002), and as shown here, PAF receptor antagonists ac-
celerate DNA repair. The implication of this finding is that
inflammatory mediators, such as PAF, depress DNA repair,
thus providing another mechanistic link between inflamma-
tion and carcinogenesis. Supporting this idea are the
observations that PAF receptor binding has been implicated
in a variety of cancers, including melanoma (Melnikova
et al., 2006), ovarian (Aponte et al., 2008), breast (Montruc-
chio et al., 1998), brain (Denizot et al., 2006), and leukemia
(Denizot et al., 2004).
In summary, our data show that agents that block
UV-induced immune suppression do so by modulating
DNA repair. Damage caused by a direct result of UV
radiation (CPD and 6–4 photoproducts), as well as damage
due to UV-induced ROS (8-oxo-dG), was reduced when the
binding of PAF to its receptor and the binding of cis-UCA to
its receptor were blocked. Moreover, treating keratinocytes
with inflammatory mediators induced DNA damage. Im-
paired DNA repair has serious consequences in humans, as
evidenced by the clinical features associated with xeroderma
pigmentosum, Cockayne syndrome, and trichothiodystrophy
(van Steeg and Kraemer, 1999). The findings reported here
confirm the important role that DNA damage and DNA repair
have in UV-induced immune suppression. Further, they
provide a mechanism describing how different UV-induced
mediators, such as PAF and cis-UCA, can regulate DNA
repair, which affects immune suppression and contributes to
UV-induced carcinogenesis.
MATERIALS AND METHODS
Mice
C57BL/6 mice were purchased from the NCI-Frederick Cancer
Research Facility, (Frederick, MD). XPA/ mice (Nakane et al.,
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1995) were bred at the Kobe University Graduate School of
Medicine (Kobe, Japan). All animals were maintained with alternat-
ing 12-hour light and dark cycles and controlled temperature and
humidity in facilities approved by the Association for Assessment
and Accreditation of Laboratory Animal Care International. The
University of Texas MD Anderson Cancer Center Institutional
Animal Care and Use Committee and the Animal Ethics Committee
of the Kobe University Graduate School of Medicine approved all
the animal procedures described here.
Reagents
cPAF, PCA-4248, 1-NPZ, and ketanserin were purchased from
Biomol Research Labs (Plymouth Meeting, PA). Dichlorofluorescein
diacetate, OPD Peroxidase substrate, and cis-UCA were purchased
from Sigma-Aldrich (St Louis, MO). The murine keratinocyte cell line
Pam 212 was a gift from Dr Stuart Yuspa, National Cancer Institute,
Bethesda, MD. Tissue culture medium was obtained from Gibco BRL
(Grand Island, NY). Biotin-SP-conjugated goat anti-mouse immuno-
globulin and peroxidase-conjugated streptavidin were purchased
from Jackson ImmunoResearch Labs (West Grove, PA). An antibody
specific for cleaved PARP was purchased from Cell Signaling
Technology (Danvers, MA). TUNEL-positive cells were detected using
a commercial kit provided by Promega (Madison, WI).
Radiation source
Mice were exposed to UV radiation supplied by a 1000 W xenon UV
solar simulator (Oriel, Stratford, CT) (Sreevidya et al., 2008). To
irradiate keratinocytes in culture, a single FS-40 sunlight was used
(Rivas and Ullrich, 1992). The intensity and spectral output of the
radiation sources were measured with an Optronics model OL-754
scanning spectrophotometer (Optronics Labs, Orlando, FL).
UDS
Pam 212 cells were treated with 50 mM of PCA-4248 and 25 mM of
1-NPZ for 30minutes at 371C. These doses were chosen on the basis
of previous studies (Walterscheid et al., 2002, 2006; Sreevidya et al.,
2008). The cells were washed extensively, overlaid with phosphate-
buffered saline, and then exposed to UV radiation (200 Jm2). The
cells were incubated for 3 hours at 371C with 10 mM of BrdU. The
cells were then fixed in methanol, and UDS was analyzed as
described (Nakagawa et al., 1998). UDS was visualized by counting
punctuated spots in the nuclei, in contrast to the uniformly intense
staining found in ordinary DNA synthesis. The grains per nuclei
counted in at least 50 cells undergoing UDS were recorded. The
percentage of cells undergoing UDS was calculated by counting at
least 10 fields per sample.
Measurement of CPD, 6–4 PP, and 8-oxo-dG
C57BL/6 mice were exposed to 2 kJm2 of UVB radiation and
injected i.p. with 1 mM of PCA-4248 or 1 mM of 1-NPZ. These doses
were chosen on the basis of previous studies (Walterscheid et al.,
2002, 2006; Sreevidya et al., 2008). Skin sections were collected at
various times post exposure and fixed as previously described
(Sreevidya et al., 2008). CPD was detected using a monoclonal
anti-thymine dimer (clone H3, Sigma-Aldrich). 6–4 photoproducts
were detected using monoclonal antibody, D195–1 clone 64M2
(MBL International, Woburn, MA). 8-oxo-dG was detected using
monoclonal antibody N45.1 (MBL International). Genomic DNA
was purified using DNeasy kit (Qiagen, Valencia, CA). CPD and
6–4 photoproducts were also measured by ELISA (MBL Interna-
tional). An ELISA to detect 8-oxo-dG was acquired from Genox
(Baltimore, MD).
Measurement of ROS
Pam 212 cells were treated with 50 mM of PCA-4248 and 25 mM of
1-NPZ. After 30minutes, the cells were washed, overlaid with
phosphate-buffered saline, and exposed to 200 Jm2 of UVB
radiation. Alternatively, some cells were treated with 10 mM of cPAF,
50 mM of 5-HT, or 50 mM of cis-UCA. The cells were washed,
trypsinized, and resuspended in 5% fetal bovine serum/Hank’s
balanced salt solution. Dichlorofluorescein diacetate (2mM) was
added, and after 1 hour at room temperature, fluorescence was
measured by flow cytometry (FACS Caliber, Becton Dickenson, San
Jose, CA). Alternatively, 1 105 Pam 212 cells were added to Lab-
Tek chamber slides (Thermo Fisher Scientific, Rochester, NY) and
cultured overnight. The cells were treated with PAF and 5-HT
receptor antagonists, and then exposed to UVB radiation, as
described above. A total of 5 mM of aminophenyl fluorescein and
5mM of hydroxyphenyl fluorescein (Sigma-Aldrich) were added. After
30minutes, the monolayers were washed and fluorescence was
detected by microscopy.
Immune suppression
Suppression of the induction of a delayed-type hypersensitivity
reaction, as described in detail elsewhere (Nghiem et al., 2002), was
used to measure the effect of UV, cis-UCA, 5-HT, and PAF on the
immune response. C57Bl/6 mice were first exposed to 15 kJm2 of
UVB radiation and immunized 5 days later with formalin-fixed
Candida albicans. Delayed-type hypersensitivity, as determined by
an increase in footpad swelling in response to a challenge with
C. albicans-specific antigen (Alerchek, Portland, ME), was measured
10 days post immunization. T4N5-containing liposomes were a gift
from Dan Yarosh (AGI-Dermatics, Freeport, NY) and were used as
previously described (Nishigori et al., 1996). Mice were injected i.p.
with 5mM cis-UCA (Walterscheid et al., 2006), 250 pM of 5-HT
(Walterscheid et al., 2006), and 500 pM of cPAF (Walterscheid et al.,
2002) to induce immune suppression, and 10 mg of anti-cis-UCA
antibody (Moodycliffe et al., 1996), 1mM of PCA-4248 (Walterscheid
et al., 2002), and 1mM of ketanserin (Walterscheid et al., 2006) to
block immune suppression. Anti-cis-UCA, PCA-4248, and ketanser-
in were injected i.p. immediately following UV exposure. There
were at least five mice per group. The mean footpad thickness for the
group ± the SEM was also calculated. A statistical difference
between the positive control and the experimental groups was
determined using a one-way ANOVA followed by the Dunnett’s
Multiple Comparison test (GraphPad Prism Software, GraphPad,
San Diego, CA).
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